Tagalogon, Morito .
HRN: 21-81-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2022
CEFTRIAXONE 1G (VIAL)
08/18/2022
08/25/2022
IV
2g
Q24H
Cap MR, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes